Rigel Pharmaceuticals, Inc. (RIGL)
NASDAQ: RIGL · Real-Time Price · USD
33.02
-1.60 (-4.62%)
At close: Mar 3, 2026, 4:00 PM EST
33.51
+0.49 (1.48%)
After-hours: Mar 3, 2026, 7:50 PM EST
Rigel Pharmaceuticals Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Rigel Pharmaceuticals stock have an average target of 43.2, with a low estimate of 24 and a high estimate of 57. The average target predicts an increase of 30.83% from the current stock price of 33.02.
Analyst Consensus: Strong Buy
* Price targets were last updated on Nov 5, 2025.
Analyst Ratings
The average analyst rating for Rigel Pharmaceuticals stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 3 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 3 | 3 | 3 | 3 | 3 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 6 | 6 | 6 | 6 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Hold → Strong Buy Upgrades $23 → $42 | Hold → Strong Buy | Upgrades | $23 → $42 | +27.20% | Nov 5, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Maintains $32 → $38 | Hold | Maintains | $32 → $38 | +15.08% | Nov 5, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $57 | Strong Buy | Reiterates | $57 | +72.62% | Oct 8, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Maintains $23 → $32 | Hold | Maintains | $23 → $32 | -3.09% | Aug 6, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Maintains $20 → $23 | Hold | Maintains | $20 → $23 | -30.35% | May 7, 2025 |
Financial Forecast
Revenue This Year
299.06M
from 179.28M
Increased by 66.81%
Revenue Next Year
288.78M
from 299.06M
Decreased by -3.44%
EPS This Year
6.76
from 0.99
Increased by 583.09%
EPS Next Year
4.14
from 6.76
Decreased by -38.76%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 309.0M | 300.4M | ||||
| Avg | 299.1M | 288.8M | ||||
| Low | 284.8M | 274.9M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 72.4% | 0.5% | ||||
| Avg | 66.8% | -3.4% | ||||
| Low | 58.8% | -8.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 7.01 | 5.23 | ||||
| Avg | 6.76 | 4.14 | ||||
| Low | 6.42 | 3.08 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 608.5% | -22.7% | ||||
| Avg | 583.1% | -38.8% | ||||
| Low | 548.4% | -54.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.